Normal view
-
Latest Science News -- ScienceDaily
-
The hidden iron switch that makes cancer cells self-destruct
Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes therapies more effective. Early mouse studies show strong potential for a new treatment approach.
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Air pollution-related immune gene prognostic signature for hepatocellular carcinoma: network toxicology, machine learning and multi-omics analysis
Front Immunol. 2025 Sep 12;16:1638445. doi: 10.3389/fimmu.2025.1638445. eCollection 2025.ABSTRACTBACKGROUND: Air pollution may crosstalk with immune system to promote hepatocellular carcinoma (HCC) development, but its precise mechanisms and prognostic significance remain unclear.OBJECTIVE: This study aims to construct a prognostic signature for HCC based on air pollutant-related immune genes (APIGs).METHODS: We obtained mRNA-seq and scRNA of HCC from GEO, TCGA and ICGC. AP-related target genes
Air pollution-related immune gene prognostic signature for hepatocellular carcinoma: network toxicology, machine learning and multi-omics analysis
Front Immunol. 2025 Sep 12;16:1638445. doi: 10.3389/fimmu.2025.1638445. eCollection 2025.
ABSTRACT
BACKGROUND: Air pollution may crosstalk with immune system to promote hepatocellular carcinoma (HCC) development, but its precise mechanisms and prognostic significance remain unclear.
OBJECTIVE: This study aims to construct a prognostic signature for HCC based on air pollutant-related immune genes (APIGs).
METHODS: We obtained mRNA-seq and scRNA of HCC from GEO, TCGA and ICGC. AP-related target genes were retrieved from several online databases. APIGs were obtained using WGCNA, differential gene expression analysis and immune infiltration analysis. Molecular subtypes were conducted based on APIG expression to characterize immune features. A total of 101 combinations of 10 machine learning algorithms were used to construct an APIG-based prognostic signature (APIGPS). Furthermore, we performed qRT-PCR, survival analyses, functional enrichment, immune infiltration and single-cell analyses. Subsequently, LASSO, RF, and RFE-SVM were employed to identify diagnostic genes, followed by pan-cancer analysis.
RESULTS: We identified 19 APIGs. HCC samples were divided into 3 subtypes, with C1 exhibiting a pro-tumor immune microenvironment and poorer prognosis. APIGPS constructed by 7 APIGs (CDC25C, MELK, ATG4B, SLC2A1, CDC25B, APEX1, GLS), demonstrated robust predictive ability independent of clinical features. The biological pathway differences between APIGPS-based high- and low-risk groups involved immune responses and cell proliferation and migration. APIGPS genes had stable binding to 7 APs and were mainly expressed in macrophages, with HRG exhibiting higher macrophage abundance. CDC25C was identified as the hub gene after intersecting diagnostic genes and APIGPS genes. CDC25C was associated with survival of 10 cancers, MSI in 10 cancers, TMB in 21 cancers, and immune cell abundance in 13 cancers.
CONCLUSIONS: We identified key APIGs and constructed a robust APIG-based prognostic signature for HCC. CDC25C was a key target through which APs impact HCC and multiple other cancers.
PMID:41019083 | PMC:PMC12463942 | DOI:10.3389/fimmu.2025.1638445
-
Nature Medicine
-
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
Nature Medicine, Published online: 29 September 2025; doi:10.1038/s41591-025-03918-xIn the proof-of-concept phase 2 ROME trial, comprehensive genomic profiling followed by molecular tumor board evaluation and randomization of patients with metastatic solid cancer to receive personalized therapy or standard of care led to a significantly higher objective response rate and longer progression-free survival in patients who received personalized therapy.
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial
Nature Medicine, Published online: 29 September 2025; doi:10.1038/s41591-025-03918-x
In the proof-of-concept phase 2 ROME trial, comprehensive genomic profiling followed by molecular tumor board evaluation and randomization of patients with metastatic solid cancer to receive personalized therapy or standard of care led to a significantly higher objective response rate and longer progression-free survival in patients who received personalized therapy.-
MedPageToday.com - medical news for physicians

-
Rise in Early Cancers: An Epidemic of Diagnosis, Not Disease?
(MedPage Today) -- The recent rise in the incidence of early-onset cancers does not necessarily mean that the occurrence of clinically meaningful cancer in young adults is increasing, researchers said. Instead, while some of the increase in early...
Rise in Early Cancers: An Epidemic of Diagnosis, Not Disease?
-
Nature - Issue - nature.com science feeds
-
How to find the papers you need to read — and avoid the ones you don’t
Nature, Published online: 29 September 2025; doi:10.1038/d41586-025-02867-2With thousands of papers being published everyday, it can be a task working out which matter. Here are some tips to help you decide.
How to find the papers you need to read — and avoid the ones you don’t
Nature, Published online: 29 September 2025; doi:10.1038/d41586-025-02867-2
With thousands of papers being published everyday, it can be a task working out which matter. Here are some tips to help you decide.-
Journal of Medical Internet Research
-
Application of Behavioral Science in Digital Therapeutics for Individuals With Prediabetes: Scoping Review
Background: Digital therapeutics are increasingly used to manage prediabetes due to their accessibility and potential for personalization. Their success depends heavily on applying behavioral science and integrating theoretical models into digital platforms. However, there has not been a comprehensive account of how behavioral science has been used in digital therapeutics for individuals with prediabetes. Objective: This scoping review aimed to examine the use of behavioral theories and techniqu
Application of Behavioral Science in Digital Therapeutics for Individuals With Prediabetes: Scoping Review
-
InfoQ

-
Article: Disaggregation in Large Language Models: The Next Evolution in AI Infrastructure
Large Language Model (LLM) inference faces a fundamental challenge: the same hardware that excels at processing input prompts struggles with generating responses, and vice versa. Disaggregated serving architectures solve this by separating these distinct computational phases, delivering throughput improvements and better resource utilization while reducing costs. By Anat Heilper
Article: Disaggregation in Large Language Models: The Next Evolution in AI Infrastructure
Large Language Model (LLM) inference faces a fundamental challenge: the same hardware that excels at processing input prompts struggles with generating responses, and vice versa. Disaggregated serving architectures solve this by separating these distinct computational phases, delivering throughput improvements and better resource utilization while reducing costs.
By Anat Heilper